Informations sur le produit
Nom:Sodium 4-Aminophenylarsonate
Marque:Biosynth
Description :Sodium 4-aminophenylarsonate (APA) is a potential biomarker for the treatment of atherosclerosis. It is an enzyme that catalyzes the degradation of nonsteroidal anti-inflammatory drugs (NSAIDs). APA also has kinetic energy and can be used as a model system for studying mitochondrial membrane potential and locomotor activity.
Sodium 4-aminophenylarsonate (APA) is a potential biomarker for the treatment of atherosclerosis. It is an enzyme that catalyzes the degradation of nonsteroidal anti-inflammatory drugs (NSAIDs). APA also has kinetic energy and can be used as a model system for studying mitochondrial membrane potential and locomotor activity.
Sodium 4-aminophenylarsonate (APA) is a potential biomarker for the treatment of atherosclerosis. It is an enzyme that catalyzes the degradation of nonsteroidal anti-inflammatory drugs (NSAIDs). APA also has kinetic energy and can be used as a model system for studying mitochondrial membrane potential and locomotor activity.
Avis:Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Propriétés chimiques
Masse moléculaire :239.04 g/mol
Formule :C6H7AsNNaO3
Degré de pureté :Min. 95%